T Cell

A T cell (or T lymphocyte) is a central leukocyte lineage of the vertebrate adaptive immune system responsible for cell-mediated immunity. Whereas B lymphocytes recognize intact, native three-dimensional macromolecules in solution via membrane-bound and secreted antibodies (humoral immunity), conventional T cells are blind to free soluble antigens; instead, they inspect the intracellular and extracellular proteome of the body by recognizing short linear peptide fragments cradled within the peptide-binding groove of Major Histocompatibility Complex (MHC) glycoproteins—termed Human Leukocyte Antigens (HLA) in humans—displayed on the cell membrane of host cells (MHC restriction, discovered by Rolf Zinkernagel and Peter Doherty in 1974).

Although T-cell progenitors originate from hematopoietic stem cells in the bone marrow (or fetal liver), they migrate via the bloodstream to complete their development, receptor gene rearrangement, and self-tolerance selection inside the thymus—the bilobed primary lymphoid organ seated in the anterior superior mediastinum from which the letter "T" in T cell is derived. Upon exiting the thymus as mature, naive T lymphocytes, they continuously recirculate through secondary lymphoid organs (lymph nodes, spleen, and mucosal Peyer's patches) to coordinate macrophage activation, B-cell antibody class switching, and direct cytotoxic elimination of virus-infected and malignant cells.

αβ vs. γδ TCR Structure and V(D)J Somatic Recombination

The antigen-recognition receptor of ~95% of circulating human T cells is a disulfide-linked transmembrane heterodimer composed of one α chain (~45 kDa) and one β chain (~45 kDa), each containing a variable (V) immunoglobulin domain—bearing three hypervariable complementarity-determining regions (CDR1, CDR2, and CDR3) that contact the peptide–MHC surface—and a constant (C) domain. A minor subset (1–5% in blood, enriched in mucosal epithelia) expresses a γδ TCR that recognizes non-peptidic phosphorylated metabolites or stress-induced MHC-like ligands without classical MHC restriction.

To generate a repertoire capable of recognizing >10⁷ distinct pathogen peptides from a single genome, developing thymocytes rearrange germline Variable (V), Diversity (D, in β and δ chains), and Joining (J) gene segments via somatic V(D)J recombination catalyzed by the lymphoid-specific recombinase enzymes RAG1 and RAG2 (Recombination-Activating Genes 1 and 2) alongside terminal deoxynucleotidyl transferase (TdT), which inserts random non-templated (N) nucleotides at the CDR3 junction— yields a theoretical combinatorial and junctional diversity of 10¹⁵ to 10¹⁸ distinct αβ TCR clonotypes.

Because the α and β chains possess extremely short cytoplasmic tails (5–12 amino acids) incapable of transducing intracellular signals, the αβ TCR associates non-covalently in the plasma membrane with the invariant CD3 signaling complex—consisting of one CD3γε heterodimer, one CD3δε heterodimer, and one homodimer of ζ (CD247) chains (ζ₂). Together, the octameric TCR–CD3 complex contains 10 Immunoreceptor Tyrosine-based Activation Motifs (ITAMs) (one on each γ, δ, and ε chain, and three on each ζ chain).

Thymic Maturation: Positive and Negative Selection

Immature thymic progenitors enter the corticomedullary junction as double-negative (DN, CD4⁻CD8⁻) thymocytes, rearrange their TCRβ locus (checked by the pre-TCR at the β-selection checkpoint), rearrange their TCRα locus, and upregulate both coreceptors to become double-positive (DP, CD4⁺CD8⁺) thymocytes in the thymic cortex. Because V(D)J recombination is stochastic, DP thymocytes must pass two stringent quality-control filters that eliminate 95% to 98% of all developing cells by apoptosis:

1. Positive Selection in the Thymic Cortex (MHC Restriction): Cortical thymic epithelial cells (cTECs) display self-peptides on MHC Class I and MHC Class II molecules. DP thymocytes whose TCRs fail to bind self-MHC at all die by neglect (>90% of thymocytes). Thymocytes whose TCRs bind self-peptide–MHC with low-to-intermediate affinity receive a survival signal and commit to a single lineage: cells recognizing MHC Class I retain CD8 and silence CD4, while cells recognizing MHC Class II retain CD4 and silence CD8, becoming single-positive (SP) thymocytes.
2. Negative Selection in the Thymic Medulla (Central Tolerance): SP thymocytes migrate into the medulla, where medullary thymic epithelial cells (mTECs) and dendritic cells test them for high-affinity self-reactivity. Crucially, mTECs express the transcription factor AIRE (Autoimmune Regulator), which drives promiscuous ectopic transcription of thousands of tissue-restricted antigens (such as pancreatic insulin, thyroid thyroglobulin, and myelin basic protein). Any thymocyte whose TCR binds self-peptide–MHC with high affinity is either deleted via clonal apoptosis or diverted into a FOXP3⁺ natural regulatory T cell (nTreg).

Immunological Synapse and Costimulation

In secondary lymphoid organs, a naive T cell encountering its cognate peptide–MHC on a professional antigen-presenting cell (APC)—principally a mature dendritic cell activated during inflammation and phagocytosis—forms a concentrically organized bullseye interface termed the immunological synapse (or Supramolecular Activation Cluster, SMAC) and requires three sequential signals for clonal expansion (proliferating ~10⁴–10⁵-fold over 5–7 days, driven by autocrine interleukin-2 [IL-2]):

• Signal 1 (Antigen Specificity): The TCR binds the peptide–MHC complex while the coreceptor (CD4 binding the β₂ domain of MHC Class II, or CD8 binding the α₃ domain of MHC Class I) brings its cytoplasmic tail-associated kinase Lck into proximity with CD3 ITAMs. Lck phosphorylates the ITAMs, recruiting ZAP-70 kinase, which phosphorylates the scaffold LAT, activating PLCγ1 (generating IP₃ → Ca²⁺ release → STIM1/ORAI1 store-operated Ca²⁺ ion channels → calcineurin → NFAT nuclear translocation, alongside DAG → PKCθ → NF-κB and Ras → AP-1).
• Signal 2 (Costimulation): Simultaneously, CD28 on the T cell must bind CD80 (B7-1) or CD86 (B7-2) on the activated APC (which only upregulates B7 ligands after sensing microbial PAMPs). Receiving Signal 1 without Signal 2 renders the T cell functionally unresponsive (clonal anergy), providing a peripheral tolerance safeguard.
• Signal 3 (Polarizing Cytokines): Cytokines secreted by the APC direct differentiation into specialized effector subsets.

Comparative Functional Subsets of T Lymphocytes

Perforin / Granzyme Exocytosis and Fas–FasL Apoptosis

When an armed CD8⁺ cytotoxic T lymphocyte (CTL) recognizes a target cell displaying a viral or mutated tumor neoantigen peptide on MHC Class I, it executes lethal hit delivery within minutes without harming adjacent healthy bystander cells through two pathways:

1. Granule Exocytosis Pathway: The CTL polarizes its microtubule-organizing center toward the immunological synapse and secretes specialized cytolytic granules containing the pore-forming protein perforin and serine proteases called granzymes (principally Granzyme B). In the presence of extracellular Ca²⁺, perforin polymerizes in the target membrane or endosome to deliver Granzyme B into the target cell cytosol, where Granzyme B directly cleaves and activates caspase-3 and Bid (triggering mitochondrial cytochrome c release) to induce rapid apoptosis before the CTL detaches to kill serially.
2. Fas Ligand (FasL / CD95L) Pathway: Surface FasL on the CTL engages the Fas (CD95) death receptor on the target cell, recruiting the FADD adapter and caspase-8.

Following pathogen clearance, ~90–95% of effector T cells undergo contraction via apoptosis, leaving behind long-lived central memory (T_CM, CCR7⁺CD62L⁺), effector memory (T_EM), and tissue-resident memory (T_RM, CD69⁺CD103⁺) T cells. To prevent immunopathology during chronic antigen stimulation, activated T cells upregulate coinhibitory immune checkpoint receptors: CTLA-4 (CD152) outcompetes CD28 for B7 ligands with 20-fold higher affinity during priming, while PD-1 (Programmed Cell Death Protein 1) binds PD-L1 / PD-L2 on peripheral tissues and tumors to recruit SHP-2 phosphatases that dephosphorylate CD28 and TCR signaling intermediates. Therapeutic blockade of CTLA-4 and PD-1 (pioneered by James P. Allison and Tasuku Honjo, 2018 Nobel Prize) and genetic engineering of autologous T cells into chimeric antigen receptor T cells (CAR-T) have revolutionized clinical oncology.

Why can CD8+ T cells inspect almost any cell in the body while CD4+ T cells only interact with professional APCs?

Viruses and malignant mutations can arise inside any nucleated somatic cell (epithelial cells, hepatocytes, myocytes). Consequently, virtually all nucleated cells constitutively express MHC Class I, loading it in the endoplasmic reticulum (via the TAP transporter) with 8–10-amino-acid peptides cleaved from cytosolic proteins by the proteasome so CD8⁺ CTLs can detect and destroy infected cells anywhere. Conversely, MHC Class II is restricted to professional APCs (dendritic cells, macrophages, B cells), which capture extracellular microbes via phagocytosis and present them to CD4⁺ helper T cells to coordinate systemic immune responses without risking bystander lysis of healthy tissues.

How do immunosuppressive drugs like cyclosporine and tacrolimus prevent organ transplant rejection?

When a T cell recognizes foreign donor MHC molecules in an allograft, TCR engagement triggers sustained Ca²⁺ influx through CRAC (ORAI1) channels. Ca²⁺–calmodulin activates the serine/threonine phosphatase calcineurin, which dephosphorylates the cytosolic transcription factor NFAT, allowing NFAT to enter the nucleus and turn on the IL-2 gene required for T-cell proliferation. Cyclosporine (bound to cyclophilin) and tacrolimus / FK506 (bound to FKBP12) physically block the active site of calcineurin, preventing NFAT nuclear translocation and halting T-cell activation.

What happens if a human lacks the FOXP3 or AIRE transcription factor?

Loss-of-function mutations in AIRE cause APS-1 (Autoimmune Polyglandular Syndrome Type 1 / APECED) because medullary thymic epithelial cells cannot display peripheral tissue antigens during negative selection, allowing self-reactive T cells to escape into the body and destroy endocrine organs. Loss-of-function mutations in X-linked FOXP3 abolish the development of CD4⁺CD25⁺ regulatory T cells (Tregs), causing IPEX syndrome (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked), a fatal neonatal multiorgan autoimmune condition driven by unchecked T-cell proliferation.

1. Davis, M. M., & Bjorkman, P. J. (1988). "T-cell antigen receptor genes and T-cell recognition." Nature, 334(6181), 395–402. https://doi.org/10.1038/334395a0
2. Klein, L., Kyewski, B., Allen, P. M., & Hogquist, K. A. (2014). "Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)." Nature Reviews Immunology, 14(6), 377–391. https://doi.org/10.1038/nri3667
3. Zhu, J., Yamane, H., & Paul, W. E. (2010). "Differentiation of effector CD4 T cell populations." Annual Review of Immunology, 28, 445–489. https://doi.org/10.1146/annurev-immunol-030409-101212
4. Pardoll, D. M. (2012). "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews Cancer, 12(4), 252–264. https://doi.org/10.1038/nrc3239